Leuprolide Terminated Phase 2 / 3 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT01377389Ipilimumab + Androgen Depravation Therapy in Prostate Cancer
NCT00860158Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer
NCT01531205Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
NCT01326312Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer